Ricardo Tovar-Miranda

Ricardo Tovar-Miranda


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2006 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
HOHoracio F. Olivo
Horacio F. Olivo
RTRicardo Tovar-Miranda
Ricardo Tovar-Miranda
EBEfraín Barragán
Efraín Barragán

11 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
TOTatiana Olivares-Bañuelos
Tatiana Olivares-Bañuelos
AGAnllely G. Gutiérrez-Rodríguez
Anllely G. Gutiérrez-Rodríguez
RMRodolfo Méndez-Bellido
Rodolfo Méndez-Bellido
RTRicardo Tovar-Miranda
Ricardo Tovar-Miranda
OAOmar Arroyo-Helguera
Omar Arroyo-Helguera
RZRossana C Zepeda
Rossana C Zepeda
Brown seaweeds contain bioactive compounds that show anti-tumorigenic effects. These characteristics have been repeatedly observed in the Lessoniaceae family. Egregia menziesii, a member of this family, is distributed in the North Pacific and its properties have been barely studied. We evaluated herein the cytotoxic and anti-proliferative activity of extracts of this seaweed, through toxicity assay in Artemia salina and lymphocytes, and MTT proliferation assay, in Bergmann glia cells, 3T3-L1 and brain cancer cell lines. E. menziesii’s extracts inhibited the spread of all the tested cell lines. The hexane extract showed the highest cytotoxic activity, while the methanol extract was moderately cytotoxic. Interestingly, seaweed extracts displayed a selective inhibition pattern. These results suggest that E. menziesii’s extracts might be good candidates for cancer prevention and the development of novel chemotherapies due to its highest cytotoxicity in transformed cells compare to glia primary cultures.

1 September 1998 in Journal of Natural Products
Verified
Journal Article
Closed access
RTRicardo Tovar-Miranda
Ricardo Tovar-Miranda
RCRaúl Cortés-García
Raúl Cortés-García
NSNorma F. Santos-Sánchez
Norma F. Santos-Sánchez
PJPedro Joseph-Nathan
Pedro Joseph-Nathan

1 June 2013 in Journal of Molecular Catalysis B: Enzymatic
Verified
Journal Article
Closed access
Gonzalo Campillo-AlvaradoGonzalo Campillo-Alvarado
Gonzalo Campillo-Alvarado
RTRicardo Tovar-Miranda
Ricardo Tovar-Miranda

1 November 1988 in Journal of Natural Products
Verified
Journal Article
Closed access
PJP. Joseph-Nathan
P. Joseph-Nathan
RTRicardo Tovar-Miranda
Ricardo Tovar-Miranda
EME. Martínez
E. Martínez
RSR. L. Santillan
R. L. Santillan

7 January 2019 in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
ACArturo Coaviche-Yoval
Arturo Coaviche-Yoval
HLHéctor Luna
Héctor Luna
RTRicardo Tovar-Miranda
Ricardo Tovar-Miranda
Marvin A. Soriano-UrsuaMarvin A. Soriano-Ursua
Marvin A. Soriano-Ursua
JTJosé G. Trujillo-Ferrara
José G. Trujillo-Ferrara
Background: Benzofurans are heterocyclic compounds with neurotropic activity. Some have been developed for the treatment of acute and degenerative neuronal injuries. Objective: The study aimed to evaluate the in silico binding of some promising benzofurans on the GABA receptors, and the in vivo neurotropic activity of benzofuran analogues (BZF 6-10) of gamma-aminobutyric acid (GABA) on a seizure model. Methods: The ligands with the best physicochemical attributes were docked on two GABA receptors (the alpha-1 subunit of GABAA-R and GBR1 subunit of GABAB-R). Selected benzofuran derivatives were synthesized by a multistep procedure and characterized. To examine the neurotropic effects, mice were pretreated with different concentrations of the compounds prior to PTZ- or 4- AP-induced seizures. We assessed acute toxicity, motor behavior, and the effects on seizures. Results: The tested ligands that complied with Lipinski’s rule of five were tested in silico with GABAA-R (ΔG = -5.51 to -5.84 kcal/mol) at the allosteric site for benzodiazepines. They bound to a similar cluster of residues as the reference compound (gaboxadol, ΔG = -5.51 kcal/mol). Synthesis was achieved with good overall yields (42-9.7%). Two compounds were selected for biological tests (BZF-7 and rac-BZF-10) on a mouse model of seizures, induced by pentylenetetrazol (PTZ) or 4-aminopyridine (4-AP). PTZ-induced seizures are associated with GABA receptors, and those 4-AP-induced with the blockage of the delayed rectifier-type potassium channel, which promotes the release of the NMDA-sensitive glutamatergic ionotropic receptor and other neurotransmitters. The biological assays demonstrated that BZF-7 and rac-BZF-10 do not protect against seizures. Indeed, BZF-7 increased the number of PTZ-induced seizures and decreased latency time. The 4-AP model apparently showed a potentiation of seizure effects after administration of the BZF-analogues, evidenced by the incidence and severity of the seizures and reduced latency time. Conclusion: The results suggest that the test compounds are GABAergic antagonists with stimulatory activity on the CNS.